User contributions
From 2009.igem.org
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 13:29, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 13:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 13:22, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La sûreté de notre projet DVS)
- 13:21, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté
- 13:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Plasmide Thérapeutique)
- 13:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Phage Lambda)
- 13:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Conclusion)
- 13:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 13:14, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 13:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Les tests en environnement ouvert)
- 13:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Libération accidentelle)
- 13:10, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Libération accidentelle)
- 13:08, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Introduction)
- 13:07, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Introduction)
- 13:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Introduction)
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)